BASF Global   |    E-Commerce   |       
    »  search
About us  |   Products & Markets  |   Innovations  |   Sustainability  |   News & Media Relations  |   Investor Relations  |   Careers
 



Further Information

Technical Information  
Brochure
Theophylline micronized - Freshen up your products
The ingredient and service portfolio for pharmaceutical manufacturers
Poster
Coatings of pellets with a new aqueous Polymer dispersion, Kollicoat® SR 30D ( II )
Generic Drug Formulations
Choline Theophyllinate Tablets (100 mg)
Etophylline + Theophylline Tablets (100 mg + 22 mg), DC
Etophylline + Theophylline Tablets (100 mg + 22 mg), WG
Sustained Release Coating of Theophylline Pellets
Theophylline Injectable Solution (4 % = 200 mg/ 5 ml)
Theophylline Sustained Release Tablets (400 mg), WG
Theophylline Sustained Release Tablets (500 mg) DC
Theophylline Tablets (100 mg)



Publications

Order Publications

Find more information about this product on WorldAccount -
BASF's information and order management platform.
 
News

June 18, 2010:
BASF one of the top three best raw materials suppliers of the Sindusfarma’s Quality 2010 Prize
(english)

June 18, 2010:
Investigating the Up Scaling Properties of a Sustained Release Coating Using Side Vented Pan Coating Technology
(english)

April 8, 2010:
BASF showcases expertise across pharmaceutical value chain at CPhI Japan 2010
(english)

Archive
Product Search

WorldAccount
WorldAccount
     
  Disclaimer     Credits     Copyright 2004    BASF SE